Advertisements



Onconova Therapeutics shares tumble 12%

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 21st, 2017

Why Did Cara Therapeutics Shares Tumble 13.6% in April?

Investors sold off shares in the pain-drug developer following a stock offering, and ahead of first-quarter earnings......»»

Category: topSource: foxnewsMay 6th, 2017

The Latest Buzz in Biotech

Shares in Juno Therapeutics and Amicus Therapeutics tumble on disappointing news, and one important drug at Pfizer takes a big step forward......»»

Category: topSource: foxnewsDec 6th, 2016

Mid-Day Market Update: U.S. Stocks Turn Higher; Nivalis Therapeutics Shares Tumble After Failed Drug Trial

  Midway through trading Tuesday, the Dow traded up 0.15 percent to 19,126.46 while the NASDAQ climbed 0.62 percent to 5,401.98. The S&P also rose, gaining 0.32 percent to 2,208.67. Leading and Lagging Sectors On Tuesday, healthcare shares gai.....»»

Category: earningsSource: benzingaNov 29th, 2016

Sarepta Therapeutics (SRPT) Shares Cross Above 200 DMA

Market News Video.....»»

Category: topSource: redinewsJun 21st, 2017

Cara Therapeutics (CARA) Stock Rises After Cr845 Trial Update

Cara Therapeutics, Inc. (CARA) shares gained 10% in late morning trading following the recent evalu.....»»

Category: topSource: zacksJun 21st, 2017

Cara Therapeutics (CARA) Stock Rises After Cr845 Trial Update

Cara Therapeutics, Inc. CARA shares gained 10% in late morning trading following the recent evaluation of its trial for Cr845. The trial will continue under the guidance of the Independent Data Monitoring Committee. read more.....»»

Category: blogSource: benzingaJun 21st, 2017

Onconova Therapeutics (ONTX) Presents At BIO International Conference 2017 - Slideshow

Onconova Therapeutics (ONTX) Presents At BIO International Conference 2017 - Slideshow.....»»

Category: topSource: seekingalphaJun 21st, 2017

Cara Therapeutics Higher After Cr845 Update

Cara Therapeutics Inc (NASDAQ: CARA) shares are trading higher by.....»»

Category: blogSource: benzingaJun 21st, 2017

Sangamo"s stock plunges after large stock offering priced well below recent prices

Shares of Sangamo Therapeutics Inc. tumbled 9.8% in premarket trade Wednesday, after the developer for genomic therapies priced a public offering of common stock well below the previous session's clos.....»»

Category: topSource: marketwatchJun 21st, 2017

Mid-Afternoon Market Update: Fang Drops After Q1 Results; Invivo Therapeutics Shares Surge

Toward the end of trading Tuesday, the Dow traded down 0.07 percent to 21,514.68 while the NASDAQ declined 0.44 percent to 6,211.49. The S&P also fell, dropping.....»»

Category: earningsSource: benzingaJun 20th, 2017

Why Occidental Petroleum Could Tumble 20%

One team of analyst contends shares of Occidental Petroleum could fall to $48. Here's why......»»

Category: blogSource: barronsJun 20th, 2017

Neos Therapeutics Slides Despite FDA Approval

Neos Therapeutics saw its shares dip on Tuesday even thought it received approval from the FDA for its treatment of ADHD......»»

Category: blogSource: 247wallstJun 20th, 2017

Market Snapshot: U.S. stocks slip after record run as weak energy shares weigh

U.S. stocks trade lower in early action as oil prices tumble, a day after the S&P 500 and Dow notched record closes......»»

Category: topSource: marketwatchJun 20th, 2017

Akcea Therapeutics Announces Potential Pricing for IPO

Akcea Therapeutics expects to price more than 9 million shares in the range of $12 to $14 apiece in an initial public offering valued up to almost $155 million......»»

Category: blogSource: 247wallstJun 20th, 2017

Mid-Day Market Update: Dow Gains 100 Points; Performant Financial Shares Tumble

Midway through trading Monday, the Dow traded up 0.47 percent to 21,485.00 while the NASDAQ climbed 1.22 percent to 6,227.04. The S&P also rose, gaining 0.67 percent to 2,449.50. read more.....»»

Category: blogSource: benzingaJun 19th, 2017

Nektar (NKTR) Stock Rallied Almost 50% This Year: Here"s Why

Shares of Nektar Therapeutics (NKTR) are up almost 48% this year so far, outperforming the Zacks classified Medical-Drugs industry's registered increase of 3.6% during this period. Shares of N.....»»

Category: topSource: zacksJun 16th, 2017

Mersana Therapeutics Closes in on IPO After Announcing Expected Price Range

Mersana Therapeutics expects to price its 5 million shares in the range of $14 to $16 apiece in an initial public offering valued up to $92 million......»»

Category: blogSource: 247wallstJun 16th, 2017

South Africa Says Mines Must Be 30% Black-Owned; Rand, Mining Shares Tumble

Not long after South Africa introduced legislation calling for the redistribution of white-owned land and business to the country's black population, in a redux of the catalyst that resulted in Zimbabwe's hyperinflation at the start of the c.....»»

Category: blogSource: zerohedgeJun 15th, 2017

Aldeyra Therapeutics stock drops 16% after mid-stage trial miss

Aldeyra Therapeutics Inc. shares dropped 16.2% in heavy morning trade Wednesday after the company said its allergic conjunctivitis drug missed its primary endpoint in a mid-stage clinical trial. Still, the company said it planned to move the drug fo.....»»

Category: topSource: marketwatchJun 14th, 2017

Aldeyra Stumbles Over Mid-Stage Clinical Results

Aldeyra Therapeutics saw its shares slide on Wednesday after the company said its allergic conjunctivitis drug missed the primary endpoint in this Phase 2b trial......»»

Category: blogSource: 247wallstJun 14th, 2017